BioRestorative Therapies, Inc.
BioRestorative Therapies, Inc. (BRTX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BRTX · as of Jun 9, 2026
Key Statistics
Explore BioRestorative Therapies, Inc. Data
brtx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 3 · Buy rate: 100.0%
Competitors & Peers
brtx competitorsBRTX
BOLT
COCP
DWTX
EDSA
EVGNStock Performance
Full HistoryAbout BioRestorative Therapies, Inc.
BioRestorative Therapies, Inc. is a life sciences company dedicated to developing regenerative medicine products and therapies. Their approach primarily utilizes adult stem cell protocols to address t…
what is biorestorative therapies, inc. · brtx stock overview · biorestorative therapies, inc. company profile · who is biorestorative therapies, inc. ceo · brtx NASDAQ · biorestorative therapies, inc. headquarters · biorestorative therapies, inc. business segments
About Stock Overview & Key Data
BioRestorative Therapies, Inc. (BRTX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Dec 5, 2012. As of the latest trading session, BRTX stock price is $0.36, with a market capitalization of $3.3M. The stock has returned -80.00% over the past 12 months and -69.32% year-to-date.
According to 3 Wall Street analysts, the consensus rating for BioRestorative Therapies, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, BioRestorative Therapies, Inc. reported revenue of $359700.00 and net income of -$14.2M. For detailed data — including BioRestorative Therapies, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, BioRestorative Therapies, Inc. (BRTX) stock price is $0.36. The stock is traded on NASDAQ under the ticker symbol BRTX. The 52-week range is $0.16 – $2.04.